文献速递糖尿病

1型糖尿病中血压与不良肾脏事件的关联

Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes.
PubMed 文献 · Diabetes Care · 2016-01-01

研究纳入1441例13至39岁1型糖尿病患者,比较不同血压水平与肾脏结局的关联,并评估既往强化或常规血糖控制策略是否修饰该关联;中位随访24年,较低血压(<120/70 mmHg)与不良肾脏结局风险降低相关,且与既往血糖控制策略无交互作用。

要点

  • 收缩压<120 mmHg与大量白蛋白尿和III期慢性肾脏病风险降低相关。
  • 舒张压<70 mmHg与大量白蛋白尿和III期慢性肾脏病风险降低相关。
  • 血压与既往DCCT血糖控制策略之间无交互作用(所有P>0.05)。

核心结论

  • 较低血压(<120/70 mmHg)与不良肾脏结局风险显著降低相关,且不受既往血糖控制策略影响;作者认为干预试验可能有助于确定目前推荐的140/90 mmHg血压目标对1型糖尿病最佳肾脏保护是否过高。

研究设计与样本

  • 研究纳入1441例13至39岁1型糖尿病患者,这些患者此前在糖尿病控制与并发症试验(DCCT)中已被随机分配接受强化或常规血糖控制。
  • 暴露为时间更新的收缩压和舒张压分类;结局包括大量白蛋白尿(>300 mg/24 h)或III期慢性肾脏病(持续估算肾小球滤过率<60 mL/min/1.73 m2)。

主要发现

  • 中位随访24年期间,发生84例III期慢性肾脏病和169例大量白蛋白尿。
  • 在调整模型中,与收缩压130至140 mmHg相比,收缩压<120 mmHg范围与大量白蛋白尿风险为0.59倍相关(95% CI 0.37-0.95),与III期慢性肾脏病风险为0.32倍相关(95% CI 0.14-0.75)。
  • 与舒张压80至90 mmHg相比,舒张压<70 mmHg范围与大量白蛋白尿风险为0.73倍相关(95% CI 0.44-1.18),与III期慢性肾脏病风险为0.47倍相关(95% CI 0.21-1.05)。
  • 血压与既往DCCT分配的血糖控制策略之间未见交互作用(所有P>0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare different blood pressure (BP) levels in their association with the risk of renal outcomes in type 1 diabetes and to determine whether an intensive glycemic control strategy modifies this association. RESEARCH DESIGN AND METHODS: We included 1,441 participants with type 1 diabetes between the ages of 13 and 39 years who had previously been randomized to receive intensive versus conventional glycemic control in the Diabetes Control and Complications Trial (DCCT). The exposures of interest were time-updated systolic BP (SBP) and diastolic BP (DBP) categories. Outcomes included macroalbuminuria (>300 mg/24 h) or stage III chronic kidney disease (CKD) (sustained estimated glomerular filtration rate <60 mL/min/1.73 m2). RESULTS: During a median follow-up time of 24 years, there were 84 cases of stage III CKD and 169 cases of macroalbuminuria. In adjusted models, SBP in the <120 mmHg range was associated with a 0.59 times higher risk of macroalbuminuria (95% CI 0.37-0.95) and a 0.32 times higher risk of stage III CKD (95% CI 0.14-0.75) compared with SBPs between 130 and 140 mmHg. DBP in the <70 mmHg range were associated with a 0.73 times higher risk of macroalbuminuria (95% CI 0.44-1.18) and a 0.47 times higher risk of stage III CKD (95% CI 0.21-1.05) compared with DBPs between 80 and 90 mmHg. No interaction was noted between BP and prior DCCT-assigned glycemic control strategy (all P > 0.05). CONCLUSIONS: A lower BP (<120/70 mmHg) was associated with a substantially lower risk of adverse renal outcomes, regardless of the prior assigned glycemic control strategy. Interventional trials may be useful to help determine whether the currently recommended BP target of 140/90 mmHg may be too high for optimal renal protection in type 1 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ku E, McCulloch CE, Mauer M, et al. Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes. Diabetes Care. 2016. PMID: 27872156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。